Immunotech Laboratories, Inc.
IMMB · OTC
12/31/2016 | 12/31/2013 | 12/31/2009 | 12/31/2005 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $306 | $547 | $0 | $0 |
| Gross Profit | -$306 | -$547 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $254 | $0 |
| G&A Expenses | $0 | $0 | $690 | $0 |
| SG&A Expenses | $165 | $56 | $690 | $2,027 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $14 | $0 |
| Operating Expenses | $165 | $56 | $959 | $2,027 |
| Operating Income | -$470 | -$603 | -$959 | -$2,027 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$23 | -$23 | -$19 | -$31,567 |
| Pre-Tax Income | -$493 | -$626 | -$978 | -$33,595 |
| Tax Expense | $0 | $0 | $0 | $1 |
| Net Income | -$493 | -$626 | -$978 | -$33,595 |
| % Margin | – | – | – | – |
| EPS | -0.001 | -0.001 | 0 | -802 |
| % Growth | 35.7% | – | 100% | – |
| EPS Diluted | -0.001 | -0.001 | 0 | -802 |
| Weighted Avg Shares Out | 572,705 | 438,314 | 0 | 42 |
| Weighted Avg Shares Out Dil | 572,705 | 438,314 | 0 | 42 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $23 | $23 | $19 | $0 |
| Depreciation & Amortization | $16 | $14 | $14 | $0 |
| EBITDA | -$454 | -$589 | -$945 | -$2,027 |
| % Margin | – | – | – | – |